EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface

Holly C Simmons iD, Joel Finney iD, Ryutaro Kotaki, Yu Adachi, Annie Park Moseman iD, Akiko Watanabe, Shengli Song iD, Lindsey R Robinson-McCarthy iD, Valerie Le Sage, Masayuki Kuraoka iD, E Ashley Moseman iD, Garnett Kelsoe und 2 weitere

mBio · 11.06.2025 · 16 (6)

DOI: 10.1128/mbio.00892-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 11.06.2025. Verfasst von Holly C Simmons und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hemagglutinin Glycoproteins, Influenza Virus, Antibodies, Viral, Influenza A virus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza infection and vaccination impart strain-specific immunity that protects against neither seasonal antigenic variants nor the next pandemic. However, antibodies directed to conserved sites can confer broad protection. Here, we identify and characterize a class of human antibodies that engage a previously undescribed, conserved epitope on the influenza hemagglutinin (HA) protein. Prototype antibody S8V1-157 binds at the normally occluded interface between the HA head and stem. Antibodies to this HA head–stem interface epitope are non-neutralizing in vitro but protect against lethal influenza infection in mice. These antibodies bind to most influenza A subtypes and seasonal human variants, and are present at low frequencies in the memory B cell populations of multiple human donors. Vaccines designed to elicit these antibodies might contribute to “universal” influenza immunity. IMPORTANCE Antibodies to the influenza virus hemagglutinin (HA) protein confer the strongest protection against infection. Human antibodies elicited by infection and/or vaccination fail to protect against antigenically novel animal, pandemic, or human seasonal viruses. Improved vaccines are needed. We identify a novel class of antibodies that bind most divergent HA subtypes and all seasonal human HA antigenic variants tested. These antibodies confer protection from lethal influenza challenge in animal models. The corresponding epitope on the HA head is occluded by its interaction with the stem and is inaccessible in the well-resolved prefusion state. The immunogenicity of this head–stem interface indicates that poorly understood conformations of HA presenting widely conserved surfaces are explored in biochemical, cell-based, and in vivo assays. Head–stem interface antibodies warrant further investigation as an avenue to improve influenza vaccines and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemagglutinin Glycoproteins, Influenza VirusAntibodies, ViralInfluenza A virusHumansAnimalsMiceEpitopesOrthomyxoviridae InfectionsInfluenza, HumanFemaleInfluenza VaccinesAntibodies, NeutralizingProtein Binding

Stichwörter der Autor:innen

antibody repertoireimmunologyinfluenzamonoclonal antibodiesprotein structure-functionvirology

Substanzen

Hemagglutinin Glycoproteins, Influenza VirusAntibodies, ViralEpitopesInfluenza VaccinesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Integrative Immunobiology, Duke University, Durham, North Carolina, USA.
  • Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan.
  • Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.

ORCID-Profile: Holly C Simmons, Joel Finney, Annie Park Moseman, Shengli Song, Lindsey R Robinson-McCarthy, Masayuki Kuraoka, E Ashley Moseman, Yoshimasa Takahashi, Kevin R McCarthy

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Japan Agency for Medical Research and Development
  • Funds from the University of Pittsburgh Center for Vaccine Research
  • NIGMS NIH HHS

Zitieren

APA

Simmons, H. C., Finney, J., Kotaki, R., Adachi, Y., Moseman, A. P., Watanabe, A., Song, S., Robinson-McCarthy, L. R., Le Sage, V., Kuraoka, M., Moseman, E. A., Kelsoe, G., Takahashi, Y., & McCarthy, K. R. (2025). A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface. mBio, 16(6). https://doi.org/10.1128/mbio.00892-25

Vancouver

Simmons HC, Finney J, Kotaki R, Adachi Y, Moseman AP, Watanabe A, et al. A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface. mBio. 2025;16(6). doi:10.1128/mbio.00892-25

BibTeX
@article{Simmons2025,
  author = {Simmons, Holly C and Finney, Joel and Kotaki, Ryutaro and Adachi, Yu and Moseman, Annie Park and Watanabe, Akiko and Song, Shengli and Robinson-McCarthy, Lindsey R and Le Sage, Valerie and Kuraoka, Masayuki and Moseman, E Ashley and Kelsoe, Garnett and Takahashi, Yoshimasa and McCarthy, Kevin R},
  title = {A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface},
  journal = {mBio},
  year = {2025},
  volume = {16},
  number = {6},
  doi = {10.1128/mbio.00892-25}
}
Kostenlos starten →